Home/Filings/4/0000950170-24-018170
4//SEC Filing

JOHNSON MICHAEL 4

Accession 0000950170-24-018170

CIK 0001180262other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 5:44 PM ET

Size

12.9 KB

Accession

0000950170-24-018170

Insider Transaction Report

Form 4
Period: 2024-02-16
JOHNSON MICHAEL
DirectorChairman & CEO
Transactions
  • Purchase

    Common Stock

    2024-02-16$8.07/sh+61,725$498,300603,707 total
  • Award

    Stock Appreciation Rights

    2024-02-16+982,800982,800 total
    Exercise: $8.07Exp: 2034-02-16Common Stock (982,800 underlying)
  • Award

    Common Stock

    2024-02-16+495,6621,099,369 total
  • Tax Payment

    Common Stock

    2024-02-16$8.07/sh30,351$244,9331,153,857 total
  • Award

    Common Stock

    2024-02-16+84,8391,184,208 total
Footnotes (5)
  • [F1]This transaction represents multiple open market purchases. The range of prices for such transactions is $7.84 to $8.20. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price.
  • [F2]Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Issuer's Board of Directors (the "Board"), subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the RSU vest prior to February 16, 2025.
  • [F3]Consists of RSUs fully vested at the time of grant.
  • [F4]Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 16, 2024.
  • [F5]Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Board, subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the SAR vest prior to February 16, 2025.

Documents

1 file

Issuer

HERBALIFE LTD.

CIK 0001180262

Entity typeother

Related Parties

1
  • filerCIK 0001311173

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:44 PM ET
Size
12.9 KB